Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocar
- This topic has 0 replies, 1 voice, and was last updated 6 years, 1 month ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma
http://cancerres.aacrjournals.org/content/early/2018/06/05/0008-5472.CAN-17-1123
Thanks to the American Association for Cancer Research for this piece.
Gavin
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.